Calidi Biotherapeutics, Inc. (CLDI) AMEX

1.62

-0.04(-2.41%)

Updated at October 16 01:56PM

Currency In USD

Valuation

Market Cap9.17M
Enterprise Value6.61M
P/E Ratio-0.23
PEG Ratio-0
Price/Sales Ratio3.1
Price/Book Ratio2.64
Enterprise/Revenue2.26
Enterprise/EBITDA-0.19

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-13.2
Operating Margin-13.28

Management Effectiveness

Return On Assets-2.12
Return On Equity1,804.73

Income Statement

Revenue0
Revenue/Share0.52
Gross Profit-1.54M
EBITDA-21.78M
Net Income-22.14M
Diluted EPS-35.7

Balance Sheet

Total Cash5.28M
Total Cash/Share1.83
Total Debt4.01M
Total Debt/Equity2.27
Current Ratio1.13
Book Value Per Share0.72

Price History

52-Week Change-88.66
52-Week High46.68
52-Week Low1.41
Moving Average 50 Days2.3
Moving Average 200 Days6.59

Statistics

Average Volume516,491
Shares Outstanding2.88M
% Held by Institutions8.27

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateAugust 05, 2025